Skip to main content
Premium Trial:

Request an Annual Quote

Integrated DNA Technologies Creates New Unit

NEW YORK (GenomeWeb News) – Integrated DNA Technologies today announced that it has created a new business unit called Clinical and Commercial Manufacturing, which will manufacture oligonucleotides for use in diagnostic products.
The firm also said that it has received ISO 13485:2003 certification at its facility in Coralville, Iowa, which houses the new unit.
"This new business unit has evolved through years of partnership and interaction with our family of customers researching and performing in vitro diagnostics,” Trey Martin, COO of IDT, said in a press release. “This arrangement allows IDT to further improve our service to these customers by offering dedicated processing, purification, analysis, formulation, functional testing and final fill services in purpose-built clean room suites with assigned senior production staff.”

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.